Key Findings:  Data suggests that cannabis using patients did not demonstrate more frequent active disease or IBD-associated complications. As such, the authors posit that other non-luminal (organ cavity) factors influenced their symptoms and/or decision to use cannabis.
Type of Study:  Meta-analysis
Study Sample Size:  383
Study Result:  Inconclusive
Study Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified